FINWIRES · TerminalLIVE
FINWIRES

HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9

By

Cardiff Oncology (CRDF) has an average rating of hold and mean price target of $4.17, according to analysts polled by FactSet.

What else is happening in Research?